Updated review of thymosin alpha-1's clinical applications: hepatitis B/C treatment, cancer immunotherapy adjuvancy, vaccine response enhancement, HIV immune reconstitution, and emerging sepsis applications.
Key findingUpdated review of thymosin alpha-1's clinical applications: hepatitis B/C treatment, cancer immunotherapy adjuvancy, vaccine response enhancement, HIV
What the researchers found
Updated review of thymosin alpha-1's clinical applications: hepatitis B/C treatment, cancer immunotherapy adjuvancy, vaccine response enhancement, HIV immune reconstitution, and emerging sepsis applications.
Why it matters
Relevant for peptide research.
How the study worked
research study.
What this study cannot tell us
See abstract.
How to read the evidence
emerging evidence.
When this study was published
Published in 2009.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
Common questions
What was studied?
What was found?
Read the original research
Thymosin alpha1: a promising molecule for important clinical applications.
Medicinski arhiv, 63(1), 48-50
Citation
Këlliçi, Sueli; Burazeri, Genc. (2009). Thymosin alpha1: a promising molecule for important clinical applications.. Medicinski arhiv, 63(1), 48-50.